Diagnogen Expands Operations to Asia and the Middle East

Diagnogen is proud to announce a significant expansion of its operations in Asia and the Middle East, with strategic headquarters established in Hong Kong and the UAE. This move ensures faster regional support and improved accessibility to our innovative in vitro diagnostic (IVD) solutions.

Diagnogen’s presence in these regions addresses growing healthcare demands by delivering advanced ELISA, CLIA, and molecular diagnostic tools. This expansion also means localized support, quicker delivery times, and tailored solutions for healthcare providers.

“Asia and the Middle East are critical to our global growth,” said a Diagnogen spokesperson. “We aim to empower healthcare providers with diagnostics that ensure early detection, accuracy, and improved patient outcomes.”

This milestone reflects Diagnogen’s commitment to enhancing preventive care and building a healthier, more connected future for all.